Interestingly, we also observed an enhanced infection of the X4-using viruses following treatment with MVC, suggesting that treatment of CD4+ T-cells with MVC increases their susceptibility to X4-using viral infection possibly due to cell activation (López-Huertas et al. 2020; Madrid-Elena et al. 2018). This evidence concerns the gene CD4 and viral infectious disease.